Long-term Follow-up for Multidrug-resistant Tuberculosis
Authors:
Open Access
- 1 April 2006
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 12 (4) , 687-688
Abstract
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.Keywords
This publication has 7 references indexed in Scilit:
- Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.2005
- Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort studyThe Lancet, 2005
- The Effect of Pulmonary Rehabilitation in Patients With Post-tuberculosis Lung DisorderChest, 2003
- Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, PeruNew England Journal of Medicine, 2003
- The Treatment of Multidrug-Resistant Tuberculosis in TurkeyNew England Journal of Medicine, 2001
- Control of multidrug resistant tuberculosisBMJ, 1999
- Community based approaches to the control of multidrug resistant tuberculosis: introducing “DOTS-plus”BMJ, 1998